Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Morgan Advanced Materials still cautious after first-half growth

(Sharecast News) - Morgan Advanced Materials has reported a robust set of half-year results on Tuesday, with a 3.4% increase in revenue to £572.6m and a 42.6% surge in group adjusted operating profit, which reached £71.3m. The FTSE 250 company said its adjusted operating profit margin expanded by 350 basis points to 12.5%, aligning with its financial framework.

Adjusted earnings per share jumped 48.5% to 14.7p, while return on invested capital improved by 100 basis points to 19.7%.

On a statutory basis, operating profit grew 32.3% to £66.8m, and profit before tax increased by 29.1% to £57.5m.

Continuing earnings per share rose 8p to 13.2p.

Despite a challenging market environment, the company said it maintained a strong balance sheet with net debt including lease liabilities at £270.5m, a 5% increase.

Free cash flow before acquisitions, disposals, and dividends improved significantly, though it remained negative at -£7.9m.

The firm highlighted an 8.2% organic revenue growth on a constant-currency basis, with faster-growing markets contributing 14.9%.

Morgan Advanced Materials also reduced its absolute scope one and two carbon dioxide-equivalent emissions by 11.6% compared to the first half of 2023.

An interim dividend of 5.4p per share was declared, a slight increase from the 5.3p per share in the first half of 2023.

Looking ahead, Morgan Advanced Materials said it remained cautious about demand in several end-markets, but expected full-year revenue growth to reach the top end of its 4% to 7% financial framework.

The company anticipated maintaining its margin at around 12.5% for the full year.

As part of its ongoing business simplification strategy, it was in the middle of reorganising into three segments - thermal products, performance carbon, and technical ceramics - a move expected to deliver £10m in annualised savings by 2025.

"We are continuing to implement our strategy successfully," said chief executive officer Pete Raby.

"Whilst our constant currency revenue growth benefited from the weaker, cyber impacted, prior year comparator, we have seen underlying revenue growth in both our core and faster-growing markets.

"Our investment in semiconductor capacity, where we continue to see strong demand and have attractive growth opportunities, along with our simplification programme, are both on-track.

"Our balance sheet remains strong."

At 0934 BST, shares in Morgan Advanced Materials were down 1.55% at 310.62p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

Ibstock earnings dip as expected in 'progressively tougher market'
(Sharecast News) - Building products manufacturer Ibstock reported a drop in full-year earnings on Thursday, in line with revised guidance, in a "progressively tougher market".
OSB hikes dividend, launches buyback after fall in profit
(Sharecast News) - OSB Group reported a decline in annual profit for 2025 on Thursday as higher administrative costs and an impairment charge weighed on earnings, though the specialist lender said loan growth and originations increased and it announced a £100m share buyback alongside a higher dividend.
Spire Healthcare grows annual profits, but NHS outlook uncertain in 2026
(Sharecast News) - Takeover target and Spire Healthcare reported a small rise in adjusted profits over 2025 which it hailed as a "resilient performance" against a backdrop of significant cost headwinds, though the outlook for 2026 was proving more uncertain due to a drop in NHS commissioning activity.
Bloomsbury shares spark on 2027 profit outlook
(Sharecast News) - Shares in Bloomsbury Publishing shot higher on Thursday after it said profit for the year ending 28 February 2027 was set to be "materially ahead" of market expectations as Sarah J. Maas will publish her next two novels within the next year.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.